Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says 0 22.01.2025 04:05 Fortune.com Compared to Lilly’s Zepbound (tirzepatide), the once-daily experimental drug would be simpler to produce. Read More Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
